Replies to post #186839 on Biotech Values

[biomaven0]

>>CMRX drops Ebola program

There was a harbinger of this that I commented on previously on SI talking about their JPM presentation:

I did note that the Chimerix slides pretty much ignored Ebola except for a reference to the trial. Not sure what that means if anything.

[DewDiligence]

CMRX -5% on delay in full enrollment of phase-3 SUPPRESS trial from early 2015 to summer of 2015:

http://finance.yahoo.com/news/chimerix-provides-anticipated-suppress-enrollment-120000307.html